Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Addeira Pharmaceuticals AB
AB
Active
Org 5592365208
Sydgatan 3, 151 38
Södertälje
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2020 · 6 years old
12 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Addeira Pharmaceuticals AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
146M
109M
73M
36M
0M
2021: 91M
91M
2021
2022: 117M (+29% vs 2021)
117M
+29%
2022
2023: 34M (-71% vs 2022)
34M
-71%
2023
2024: 81M (+138% vs 2023)
81M
+138%
2024
2025: 96M (+19% vs 2024)
96M
+19%
2025
EBITDA
SEK millions
75M
56M
37M
19M
0M
2021: 18M
18M
2021
2022: 60M (+233% vs 2021)
60M
+233%
2022
2023: 7M (-88% vs 2022)
7M
-88%
2023
2024: 21M (+200% vs 2023)
21M
+200%
2024
2025: 19M (-10% vs 2024)
19M
-10%
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
96 051
81 344
33 999
117 418
90 667
Staff expenses
−10 067
−5 228
−3 780
−3 902
—
EBITDA
19 454
21 403
6 597
60 381
17 695
Depreciation & amort.
−1 374
−41
−54
−54
−0
EBIT
18 080
21 362
6 543
60 327
17 695
Net financials
−844
313
−2 266
1 536
461
Profit before tax
17 236
21 675
4 277
61 862
18 156
Tax
−3 670
−4 553
−1 499
−12 748
−3 754
Net profit
13 565
17 121
2 778
49 114
14 402
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
68 945
44 466
45 323
71 156
29 358
Equity
35 232
24 039
6 917
49 139
14 427
Long-term debt
—
—
—
—
0
Short-term debt
33 713
20 427
38 406
22 017
14 931
Total debt
33 713
20 427
38 406
22 017
14 931
Financial ratios
5-year trend
EBITDA margin
20,3 %
This company
15,8 %
Market median
This company
Market median
28% above market
2021
2025
Equity ratio
51,1 %
This company
38,2 %
Market median
This company
Market median
34% above market
2021
2025
Return on equity
38,5 %
This company
18,4 %
Market median
This company
Market median
109% above market
2021
2025
Net profit margin
14,1 %
This company
8,1 %
Market median
This company
Market median
74% above market
2021
2025
Asset turnover
1,39×
This company
1,12×
Market median
This company
Market median
24% above market
2021
2025
Debt / equity
0,96×
This company
0,62×
Market median
This company
Market median
55% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Addeira Pharmaceuticals AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
